Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and l-dopa toxicity

► Mitochondria dysfunction-oxidative stress-apoptosis have a role in PD pathogenesis. ► α-Lipoic acid provided early neuroprotection by intervention of this pathogenesis. ► l-Dopa was found to deteriorate PD pathogenesis despite symptomatic motor relief. ► α-Lipoic acid efficiently halted the delete...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience research Jg. 71; H. 4; S. 387 - 395
Hauptverfasser: Abdin, Amany A., Sarhan, Naglaa I.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Ireland Elsevier Ireland Ltd 01.12.2011
Schlagworte:
Animals
Antiparkinson Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Disease Models, Animal
l-Dopa
Levodopa - pharmacology
Mitochondria - drug effects
Mitochondrial dysfunction
Neurons - drug effects
Neurons - ultrastructure
Neuroprotective Agents - pharmacology
Oxidative stress
Oxidative Stress - drug effects
Parkinson Disease - pathology
Parkinson's disease
Rats
Rotenone - toxicity
Thioctic Acid - pharmacology
Uncoupling Agents - toxicity
α-Lipoic acid
α-Lipoic acid
Oxidative stress
Parkinson's disease
Mitochondrial dysfunction
l-Dopa
Apoptosis
ISSN:0168-0102, 1872-8111, 1872-8111
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:► Mitochondria dysfunction-oxidative stress-apoptosis have a role in PD pathogenesis. ► α-Lipoic acid provided early neuroprotection by intervention of this pathogenesis. ► l-Dopa was found to deteriorate PD pathogenesis despite symptomatic motor relief. ► α-Lipoic acid efficiently halted the deleterious effects of l-dopa. ► α-Lipoic acid recommended as a disease-modifying therapy with l-dopa in early PD. The current study evidenced hypothesis that mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways play a critical role in degeneration of dopaminergic neurons in Parkinson's disease. Model of rotenone-induced parkinsonism in rats produced decrease in striatal complex I activity and reduced glutathione with increase in nitrites concentration and caspase-3 activity. This was confirmed by significant correlation of catalepsy score with neurochemical parameters. Moreover, electron microscopic examination of striatal neurons displayed ultrastructure affection as hyperchromatic nuclei and disrupted mitochondria that are typical features of undergoing apoptosis. Administration of l-dopa as replacement therapy, although caused symptomatic improvement in catalepsy score, but further worsening in neurochemical parameters. Therefore, efforts are not only to improve effect of l-dopa, but also to introduce drugs provide antiparkinsonian and neuroprotective effects. In this study, α-lipoic acid exhibited noticeable neuroprotective effects by a mechanism via intervention of mitochondrial dysfunction-oxidative stress-dependent apoptotic pathways. Combination of α-lipoic acid efficiently halting deleterious toxic effects of l-dopa, revealed normalization of catalepsy score in addition to amelioration of neurochemical parameters and apparent preservation of striatal ultrastructure integrity, indicating benefit of both symptomatic and neuroprotective therapy. In conclusion, α-lipoic acid could be recommended as a disease-modifying therapy when given with l-dopa early in course of Parkinson's disease.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-0102
1872-8111
1872-8111
DOI:10.1016/j.neures.2011.08.008